Dr. Reddy's Laboratories 配当と自社株買い
配当金 基準チェック /56
Dr. Reddy's Laboratories配当を支払う会社であり、現在の利回りは0.67%で、収益によって十分にカバーされています。
主要情報
0.7%
配当利回り
-0.02%
バイバック利回り
| 総株主利回り | 0.7% |
| 将来の配当利回り | 1.1% |
| 配当成長 | -0.5% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ₹8.000 |
| 配当性向 | 12% |
最近の配当と自社株買いの更新
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05決済の安定と成長
配当データの取得
安定した配当: DRREDDYの1株当たり配当金は過去10年間安定しています。
増加する配当: DRREDDYの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| Dr. Reddy's Laboratories 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (DRREDDY) | 0.7% |
| 市場下位25% (IN) | 0.2% |
| 市場トップ25% (IN) | 1.1% |
| 業界平均 (Pharmaceuticals) | 0.7% |
| アナリスト予想 (DRREDDY) (最長3年) | 1.1% |
注目すべき配当: DRREDDYの配当金 ( 0.67% ) はIndian市場の配当金支払者の下位 25% ( 0.24% ) よりも高くなっています。
高配当: DRREDDYの配当金 ( 0.67% ) はIndian市場の配当金支払者の上位 25% ( 1.12% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: DRREDDYの配当性向は低く ( 12.5% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: 現在の現金配当性向（ 75.5% ）では、 DRREDDYの配当金はキャッシュフローによって賄われています。